| HIV Infection |
1 |
1 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.97 |
| Adherence |
0 |
0.62 |
| Preexposure HIV Prophylaxis |
0 |
0.99 |
| Food and Drug Administration (FDA) |
0 |
0.98 |
| Viral Load |
0 |
0.31 |
| Protease Inhibitor |
0 |
0.22 |
| Clinical Research |
0 |
0.15 |
| Dorsum |
0 |
0.15 |
| Pain |
0 |
0.15 |
| Prophylaxis |
0 |
0.15 |
| Proteases |
0 |
0.15 |
| Transgender |
0 |
0.15 |
| Weight Gain |
0 |
0.15 |
| Weight Loss |
0 |
0.15 |
| Weight Management |
0 |
0.14 |
| Pain Management |
0 |
0.07 |
| Social Determinants of Health |
0 |
0.07 |